SteriLumen Revenue and Competitors

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • SteriLumen's estimated annual revenue is currently $1.4M per year.(i)
  • SteriLumen's estimated revenue per employee is $87,000

Employee Data

  • SteriLumen has 16 Employees.(i)
  • SteriLumen grew their employee count by -11% last year.

SteriLumen's People

NameTitleEmail/Phone
1
Account ExecutiveReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.5M7-30%N/AN/A
#2
$2M205%N/AN/A
#3
$85.4M471-1%N/AN/A
#4
$1.5M17N/AN/AN/A
#5
$0.4M60%N/AN/A
#6
$1M1110%N/AN/A
#7
$0.3M4-20%N/AN/A
#8
$0.6M80%N/AN/A
#9
$2.3M23N/AN/AN/A
#10
$15.7M108-4%N/AN/A
Add Company

What Is SteriLumen?

SteriLumen was founded in 2016 to provide novel, easy to deploy and effective devices to protect vulnerable populations from dangerous infections. Our engineers create patented products that employ proven germicidal UVC in a variety of automated and connected designs, rising to meet the disinfection challenges in our most important industries. Our guiding principle is to create safe environments without creating emissions of ozone or other chemicals, and provide the modern convenience of connected, remote asset management capabilities that enable Data Driven Disinfectionâ„¢. In 2020 we formed a strategic partnership with Akida LLC, makers of the NASA-commissioned Airocideâ„¢ product line to address air-borne pathogens and bring market-leading air purification technology to the fight against coronavirus. Together, our advanced designs and infection control technologies significantly lower the risk of infection, controlling outbreaks and allowing businesses to get back to what they do best. We are a wholly owned subsidiary of Applied UV Inc. (NASDAQ:AUVI).

keywords:N/A

N/A

Total Funding

16

Number of Employees

$1.4M

Revenue (est)

-11%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.4M16-24%N/A
#2
$2.4M167%N/A
#3
$1.2M16-6%N/A
#4
$1.2M16-20%N/A
#5
$1.4M17-6%N/A